-
Most Recent
Search Results
240 results for CEL
CVM Stock Earnings: CEL-SCI Reported Results for Q2 2024
CEL-SCI just reported results for the second quarter of 2024.
Celsius Price Predictions: Where Will the CEL Crypto Go After Major Crash?
Celsius (CEL) price predictions are on the mind of traders today as they deal with a crypto crash that pulling the market down.
Welcome to the President’s Market
Federal investment is driving explosive stock moves as Washington reshapes supply chains tied to AI, energy, and national security.
Why Is CEL-SCI (CVM) Stock Down 23% Today?
CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.
CVM Stock: Why Cancer Play Cel-Sci Is Riding the Reddit Wave
CVM stock is on the move after Cel-Sci CEO Geert Kersten joined the battle against GME stock short-sellers. Here’s what to know.
CVM Stock Earnings: CEL-SCI Misses EPS for Q3 2024
CVM stock results show that CEL-SCI missed analyst estimates for earnings per share the third quarter of 2024.
Celsius Network Looks to Return Customer Funds, Reversing CEL Crypto Losses
The Celsius Network is seeing CEL crypto prices fly upward in response to its motion in court to return $50 million in user funds.
CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy
Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.
CRSP Stock Alert: Can CRISPR Therapeutics Short Squeeze Higher?
CRSP stock is rallying after an FDA panel appeared to view CRISPR Therapeutics’ sickle-cell anemia treatment as safe.
Go Long CEL, Short DTV
Cellcom Israel Ltd. (NYSE: CEL) is ready for another leg up, while DIRECTV (NASDAQ: DTV) is encountering overhead resistance.
Why Is Crispr Therapeutics (CRSP) Stock Up Today?
Crispr Therapeutics (CRSP) stock is gaining on Tuesday after the FDA granted exagamglogene autotemcel (exa-cel) a rolling review.
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock.
CVM Stock: The Big Trial News That Has Cel-Sci Plunging Today
Today, the trial results reported by Cel-Sci missed the mark, and investors are pricing in additional risks with CVM stock.
‘Holy Grail’ Dividend Stock Yielding 11%
Foreign telcom dividend stock Partner Communications (NASDAQ: PTNR) offers low risk and above-average projected returns.
Advance Token to GO or Play it Safe?
Every once in a while, stocks blast out of a narrow base and never look back.
Hottest Services Stocks Now – IRM CEL SHLD CTRP
Services stocks fell 0.4% on Wall Street so far on Wednesday. NYSE:IRM, NYSE:CEL, NASDAQ:SHLD, NASDAQ:CTRP, NYSE:HTZ, NYSE:RCL, NYSE:OIBR, NYSE:TLK, NYSE:KKD, NYSE:BIN, NYSE:WAC, NYSE:HF, NASDAQ:MFRM, NASDAQ:TTEK,…
3 Biotech Moonshots With Imminent Catalyst Potential
Biotech has been one of the most explosive sectors. Better, further upside is likely, thanks to some of the top biotech stocks with catalysts.
Biggest Movers in Services Stocks Now – WAC CLH CEL PEI
Services stocks declined broadly 0.7% on Wall Street today. NYSE:WAC, NYSE:CLH, NYSE:CEL, NYSE:PEI, NYSE:TEO, NYSE:AER, NASDAQ:FIVE, NYSE:DLR, NYSE:WU, NASDAQ:FTR, NASDAQ:DTV, NASDAQ:APOL, NYSE:WTW, NASDAQ:FSRV, NYSE:LHO, NASDAQ:ULTA,…
Celsius Network Hampered by One-Two Punch of Harsh Accusations
The Celsius Network is facing new controversy as regulators claim the company misled investors and the cofounder files his shares as “worthless.”
Biggest Movers in Services Stocks Now – CTRP Z CEL RAD
Services stocks advanced broadly on Wall Street on Thursday morning, with the sector seeing an overall increase of 0.1%. NASDAQ:CTRP, NASDAQ:Z, NYSE:CEL, NYSE:RAD, NASDAQ:SBGI, NASDAQ:PTNR,…
5 Dividend Picks Set to Break Out
High yield dividend stocks are great investments right now. Here are five stocks on Bryan Perry’s dividend watch list.
3 – 10 of 240 results
